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Abstract The objective of this study was to determine
the rate of selected cardiac pathologies (conduction
disorders, valve regurgitation and diastolic dysfunc-
tion) in patients with long-standing ankylosing spon-
dylitis (AS) and compare the results with the
prevalence in the normal population. A rheumatologic
(structured questionnaire interview) and cardiac eval-
uation (resting electrocardiography and echocardiog-
raphy) was performed in 100 male subjects with AS
and a disease duration of more than 15 years. The
rates for conduction disorders, aortic and mitral valve
regurgitation and diastolic dysfunction were compared
with the corresponding results in the literature among
the normal population. In patients with long-standing
AS there was no increased rate for valve regurgitation
(mitral and aortic valve) and for arrhythmia. Diastolic
dysfunction occurred more often in patients with long-
standing AS. However, this might be caused by the
presence of other cardiovascular risk factors such as
age and hypertension. According to these results, a
cardiologic evaluation with echocardiography should
not be recommended routinely in patients with long-
standing AS. To conﬁrm these results, a large pro-
spective study with patients with long-standing AS and
with a matched control group should be performed in
the future.
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Introduction
Ankylosing spondylitis (AS) is a chronic systemic
inﬂammatory rheumatic disorder that primarily aﬀects
the axial skeleton and mainly involves young male
subjects [1]. Peripheral joints, tendons and ligaments
may also be aﬀected. Uveitis is the most common
extraskeletal manifestation; less frequently cardiovas-
cular and pulmonary involvement occurs [1].
Based on the ﬁndings in the literature the prevalence of
heart pathologies in patients withAS can reach up to 64%
[2]. Various studies indicate a higher rate of conduction
disturbances, valvular heart diseases and cardiomyopa-
thies in patients with AS when compared with the normal
population [3–6]. Conduction disturbances of the heart,
such as atrioventricular blocks (AVB), bundle-branch
blocks and intraventricular blocks have been observed
regularly [3, 5, 7–12]. Screening for a prolonged QT time
has been recommended since it might be associated with
HLA-B27 [12]. Various pathologies may aﬀect the heart
valves, mainly the aortic valve [13]. The spectrum of these
structural changes is wide and can range from only minor
thickening of the valves or nodules on the valves to severe
regurgitation requiring surgical replacement of the af-
fected valve. Clinical signs of cardiomyopathy were often
associated with diastolic and/or systolic dysfunction of
the ventricles [2, 4, 5, 14–20].
As a consequence of these pathologies, heart insuﬃ-
ciency and stroke were found to be increased in patients
with AS [2, 11, 21, 22]. This is associated with a de-
creased life expectancy in this population [23, 24].
In daily clinical practice symptoms of heart
involvement are rarely seen. However, the importance
of these pathologies might be underestimated. The aim
of this study was to determine the rate of heart
abnormalities in patients suﬀering from AS for more
than 15 years compared to the rate in the normal
population.
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Materials and methods
Subjects
One hundred men (32–86 years, 54.9±10.1 years) with
AS diagnosed for more than 15 years participated in this
cross-sectional study. The ﬁrst 100 volunteers who
responded to an advertisement in the newsletter of the
Ankylosing Spondylitis Society of Switzerland in July
2001 were included in the study. The Ankylosing
Spondylitis Society of Switzerland is a self-help organi-
zation run by patients aﬄicted with the disease. The
study design has been approved by the Ethics Commit-
tee of Balgrist University Hospital (Spezialisierte Un-
terkomission fu¨r Orthopa¨die der Kantonalen
Ethikkommission, Zurich, Switzerland) and informed
consent was obtained from all participants.
Included were male patients with a diagnosis of AS
and a disease duration of more than 15 years. The
diagnosis of AS was based on a clinical examination
performed by a physiatrist or a rheumatologist with
experience in treating patients with AS. In a few cases,
the diagnosis needed to be conﬁrmed by reading previ-
ous X-rays. Since the majority of the patients were
treated for AS for over 15 years by board certiﬁed
rheumatologists, no complete work-up was performed
to conﬁrm the diagnosis.
Exclusion criteria were a disease duration of less than
15 years, female gender, manifest psoriasis or psoriatic
arthritis and Reiter’s syndrome.
All participants underwent a rheumatologic and a
cardiac evaluation. The examinations were performed
between August 2001 and May 2002.
Rheumatologic evaluation
The rheumatologic evaluation included a structured
interview. Questions of the interview included age at
onset of ﬁrst symptoms of AS, age at diagnosis and
presence of HLA-B27. Table 1 summarizes the results of
the rheumatologic evaluation.
Cardiac evaluation
Three board certiﬁed cardiologists carried out the car-
diac evaluation. The patients were assigned equally to
one of the three participating cardiologists, who per-
formed an examination according to a prespeciﬁed
protocol. Resting electrocardiography (ECG) was per-
formed to detect arrhythmia. Doppler echocardiography
revealed possible mitral or aortal valve regurgitation and
abnormal ventricular diastolic function (Five Great,
1.7 MHz, General Electric, Sonos, 5500-2, 1–4 MHz,
Philips and Vingmed Vivid 5, 2.5 MHz, General Elec-
tric). The resulting data were compared with the rate of
the same pathologies in the normal population based on
a review of the existing literature.
Standardized deﬁnitions were used to categorize the
pathologies (hypertension [25], atrioventricular block
[26], bundle-branch block [26] and left ventricular
hypertrophy (resting ECG) [27]). A prespeciﬁed protocol
for the echocardiography of the left ventricle [28, 32] and
for valve regurgitation was used [29].
Literature search
A literature search was performed in order to get cor-
responding data for the normal population. MEDLINE
(PubMed) was screened between 1988 and 2002 for
studies investigating the rate of conduction disorders,
aortic and mitral valve regurgitation and ventricular
diastolic dysfunction in the normal population. Popu-
lation-based, cross-sectional surveys with a clearly de-
ﬁned clinical examination protocol (ECG and
echocardiography) for determining cardiac anomalies
were considered as most appropriate. The criteria for
consideration included the screening for pathologies
such as conduction disorders, valve regurgitation and
ventricular diastolic dysfunction in a large number of
asymptomatic participants and—if possible—among
male subjects.
Statistics
Descriptive statistical methods were used to calculate
means and standard deviation (SD). The chi-square test
was used to detect diﬀerences between the study results
(conduction disturbances, aortic and mitral valve
regurgitation) and the data in the literature. To calculate
the p value for abnormal ventricular diastolic function
the one-sample t-test was used. Statistical signiﬁcance
was considered with a p value of <0.05.
Results
Results of rheumatologic evaluation
One hundred men were enrolled in this study. All vol-
unteers fulﬁlled the inclusion criteria and there were no
Table 1 Summary of rheumatologic evaluation (n=100)
Age 54.9 (±10.1, range: 32–86) years
Age at ﬁrst diagnosis 22 (±6.7, 7–40) years
Age at diagnosis 30.4 (±10.4, 12–71) years
Latency from ﬁrst
symptoms to diagnosis
8.4 (±8.5, 0–54) years
Duration of disease 32.9 (±10.2, 16–69) years
HLA-B27 Positive 47%
Negative 5%
Unknown 48%
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exclusions or dropouts. The average age of the partici-
pants was 54.9 years (range: 32–86 years, ±10.1 years)
and ﬁrst symptoms occurred at the age of 22 years (7–
40, ±6.7). On average, the diagnosis was made at the
age of 30 years (12–71, ±10.4) with a delay of 8.4 years
(0–54, ±8.5) after the ﬁrst symptoms occurred. The
mean duration of the disease was 33 years (16–69,
±10.2).
Results of cardiac evaluation
Conduction abnormalities
A tachy–brady syndrome was detected in one patient.
Atrial ﬁbrillation was demonstrated in two patients. An
atrioventricular block was found in nine patients. Eight
suﬀered from a grade I atrioventricular block. One
subject showed a grade III atrioventricular block treated
by a pacemaker.
Incomplete left bundle-branch block was observed in
14 patients and in 5 patients a complete left bundle-
branch block was present.
Mitral and aortic regurgitation
Twenty-nine patients showed a mitral valve regurgita-
tion. An aortic regurgitation was detected in ten pa-
tients. Valvular insuﬃciencies were of mild to moderate
severity (grade I in 33 patients and grade II in 5 patients)
with the exception of one grade III mitral regurgitation.
Left ventricular dysfunction
Left ventricular diastolic dysfunction was found in 29
subjects. The severity of this impaired function was mild
in 11 patients and moderate in 18 subjects. The ratio of
the early diastolic mitral inﬂow velocity and the late
diastolic mitral inﬂow velocity (E/A ratio) was 1.113.
Sixty-nine percent of the patients with left ventricular
diastolic dysfunction suﬀered from arterial hyperten-
sion, whereas only 23.8% of the participants without
diastolic dysfunction showed hypertensive blood pres-
sure values. The results are summarized in Table 2.
Results compared with the ﬁndings of heart aﬀections
in the normal population
The results are summarized in Table 3
Conduction disorders
To be able to compare our data with corresponding
results in the literature, the following pathologies were
considered as an arrhythmia: atrial ﬁbrillation, supra-
ventricular and ventricular tachycardias, atrioventricu-
lar rhythm, ectopic atrial and ventricular beats and
atrioventricular blocks. According to this deﬁnition,
four participants were diagnosed with an arrhythmia:
atrial ﬁbrillation was found in two cases, grade III
atrioventricular block and tachy–brady syndrome were
found in one patient each.
Three articles fulﬁlled the prespeciﬁed selection cri-
teria and were used to compare our data [30–32]. In our
study the prevalence of cardiac blocks (atrioventricular
blocks, complete and incomplete left bundle-branch
block) was 5 and 7% for arrhythmia. The calculated
prevalence in the literature among the normal popula-
tion was 12.1% for conduction blocks and 8.4% for
arrhythmia. The resulting p value of 0.03 even indicates
a lower prevalence for conduction blocks in our popu-
lation with long-standing AS. There was no statistical
diﬀerence for arrhythmia with a p value of 0.72.
Mitral and aortic valve regurgitation
The frequency of aortic or mitral valve regurgitation in
our study was compared with the results of eight articles
in the literature [33–40].
In our study, the prevalence for mitral regurgitation
(MR, 29%) and aortic regurgitation (AR, 10%) was
slightly increased when compared to the calculated
prevalence in the literature (MR 21.8%, AR 6.78%).
The p values of 0.09 for MR and 0.22 for AR did not
reach statistical signiﬁcance.
Diastolic dysfunction
The prevalence of left ventricular diastolic dysfunction
in our study was compared with the results of three
published studies performed in asymptomatic volunteers
[41–43]. The mean E/A ratio of these studies among the
normal population was 1.28. In our study population
with long-standing AS the E/A ratio was 1.13 and
Table 2 Summary of cardiac evaluation (n=100)
Pathology n Severity
Tachy–brady syndrome 1
Atrial ﬁbrillation 2
Atrioventricular block 9 Grade I: 8
Grade II: 0
Grade III: 1
Left bundle-branch block 19 Incomplete 14
Complete: 5
Mitral regurgitation 29 Grade I: 26
Grade II: 2
Grade III: 1
Aortic regurgitation 10 Grade I: 7
Grade II: 3
Grade III: 0
E/A ratioa 29 Grade I: 11
Grade II: 18
aEarly diastolic inﬂow velocity/late diastolic inﬂow velocity
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reached statistical signiﬁcance (p<0.001) when com-
pared with the data in the literature.
Discussion
Heart pathologies such as conduction disorders, valve
regurgitation and diastolic ventricular dysfunction have
a direct impact on management and treatment. They are
associated with an increased risk for complications
(endocarditis and arrhythmia).
The goal of this study was to determine whether there
was a higher rate of speciﬁc cardiac pathologies in male
patients with long-standing AS for more than 15 years
compared to the normal population.
Our major ﬁnding was a trend (without reaching
statistical signiﬁcance) towards an increased rate for
mild to moderate aortic and mitral regurgitation com-
pared to the normal population. The rate of conduction
disorders in long-standing AS was comparable to the
normal population. Left ventricular diastolic dysfunc-
tion occurred statistically more often in patients with
long-standing AS than in the normal population.
However, since 69% of the patients with a left ventric-
ular diastolic dysfunction also suﬀered from hyperten-
sion, it may be assumed that this dysfunction is related
to hypertension or age and is not caused by inﬂamma-
tory changes in the myocardium of patients with
long-standing AS. It has been shown that age and
hypertension are two important risk factors for diastolic
dysfunction [28].
We compared our data with the results of previous
studies examining heart pathologies in long-standing
AS. The rate of conduction disorders in the literature
varied between 3 [9] and 23% [44]. A wide range was
observed for atrioventricular blocks from 3 [9] to 33%
[44] as well as for bundle-branch blocks from 1.1 [9] to
33% [45]. In our study the prevalence for conduction
disorders was 5% and was even lower than the rate in
the normal population (12.1%). The rate of valvular
dysfunction in long-standing AS in the literature rapidly
changed with the progress of examination techniques.
Between 1970 and 1983 the average prevalence of aortic
valve regurgitation was 6.9% in the reviewed literature.
These studies were based on clinical examination and
autopsy studies. Because of a better sensitivity and
speciﬁcity this rate increased to an average of 10.8%
(range: 1.8 [2] to 16% [22]) with the introduction of
(colour Doppler) echocardiography and transoesopha-
geal echocardiography between 1987 and 2001. In this
study the rate for aortic valve regurgitation was 10%.
Seventy percent of these patients showed a grade I and
30% a grade II regurgitation. The rate of mitral valve
regurgitation in long-standing AS was examined in only
two previous studies and varied from 32 [22] to 40%
[15]. The authors did not diﬀerentiate the severity of
these pathologies. The rate for mitral valve regurgitation
in our study was 29%, of which 26 patients showed
grade I, 2 subjects grade II and 1 patient grade III
regurgitation.
In the literature after 1987 the rate of diastolic dys-
function in patients with long-standing AS showed a
wide range from 1.4 [14] to 63.7% [2] with a calculated
mean of 26.3%. This is comparable the results of our
study with a calculated mean of 29%.
The strength of this study is the examination of a
homogeneous population of only male patients with
long-standing AS for over 15 years. To the best of our
knowledge, no previous study examined such a large
number of patients with such a long mean disease
duration of 32.2 years.
A number of restrictions concerning this study should
be mentioned. First, the diagnosis of long-standing AS
has not been veriﬁed formally. We assumed a correct
diagnosis by the fact that the patients were treated by
board certiﬁed rheumatologists, had a disease duration
of more than 15 years and showed typical signs of AS in
our own clinical examination. Second, no epidemiolog-
ical studies on the prevalence of these selected heart
pathologies have been conducted in Switzerland.
Therefore, the comparison of our data with the corre-
sponding results from the normal population relied on
studies from other countries (Belgium, France, Ger-
many, Italy, Sweden and the United States of America).
A third concern relates to the selection of our control
group. We compared our results of 100 patients with
long-standing AS with the results of the normal popu-
lation in the existing literature for two main reasons.
Due to a limited budget, we decided to examine as many
patients with long-standing AS as possible rather than
having a small AS patient sample and recruiting a small
control group of asymptomatic volunteers without AS
Table 3 Summary: comparison with corresponding results from the literature in the normal population
Pathology Prevalence in this study Prevalence in the literature p value
Arrhythmiaa 7% 8.4% 0.72
Conduction abnormalities 5% 12.1% 0.03*
Mitral regurgitation 29% 21.8% 0.09
Aortic regurgitation 10% 6.78% 0.22
Diastolic dysfunction (E/A ratiob) 1.113 1.28 <0.0001*
*Statistically signiﬁcant (p<0.05)
aThe following pathologies were considered as ‘‘arrhythmia’’: atrial ﬁbrillation, supraventricular and ventricular tachycardias, atrio-
ventricular rhythm, ectopic atrial and ventricular beats and atrioventricular blocks
bEarly diastolic mitral inﬂow velocity/late diastolic mitral inﬂow velocity
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at the same time. We assumed that large epidemiological
studies in normal populations provide more reliable
results than a small control group. However, our ﬁnd-
ings might also reﬂect important diﬀerences in clinical,
demographic, social or environmental factors inﬂuenc-
ing outcome between our study population and that
reported in the literature. Furthermore, since the sam-
ples of the participants of our study were recruited from
the Ankylosing Spondylitis Society of Switzerland the
study population might not be representative for a larger
population.
The results of this study suggest that the impact of
cardiac abnormalities in patients with long-standing AS
might have been overestimated in the past. The major
ﬁnding was a statistically not signiﬁcant diﬀerence of
mitral and aortic valve regurgitation in patients with
long-standing AS. According to these results, a cardio-
logic evaluation with echocardiography should not be
recommended routinely in patients with long-standing
AS. To conﬁrm these results, a large prospective study
with patients with long-standing AS and with a matched
control group should be performed in the future.
Take home message
The impact of cardiac abnormalities in patients with
long-standing AS might have been overestimated in the
past. According to the results of this study, a cardiologic
evaluation with echocardiography should not be rec-
ommended routinely in patients with long-standing AS.
To conﬁrm these results, a large prospective study with
patients with long-standing AS and a matched control
group should be performed in the future.
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